GLR Partners, LLC
Source: SEC Form 13F · as of Mar 2026GLR Partners, LLC holds 5 biotech & pharma companies tracked by BioSniper, totaling $3.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$3.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for PRECIGEN, INC. (PGEN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PGENPRECIGEN, INC. | 412,047 | $1.6M |
| BRNSBarinthus Biotherapeutics plc. | 1,243,377 | $707K |
| GILDGILEAD SCIENCES, INC. | 3,748 | $522K |
| REGNREGENERON PHARMACEUTICALS, INC. | 350 | $270K |
| IBRXImmunityBio, Inc. | 20,000 | $153K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.